Morphine
Duramorph, INFUMORPH 200, INFUMORPH 500, MITIGO, MS Contin, Opium Tincture Deodorized
Opioid Agonist
NADAC/unit
$0.0443
Active Shortage
Tier 1: 259.6%
PA Req: 252.0%
15 Manufacturers
62 ANDAs
Morphine relieves moderate to severe pain by acting on opioid receptors in the brain.
vs. brand Duramorph: Generic saves up to 100% per unit
Active Shortages
2025-12-22 Discontinuation of the manufacture of the drug, Upsher-Smith Laboratories, LLC
2025-12-22 Discontinuation of the manufacture of the drug, Upsher-Smith Laboratories, LLC
2025-07-08 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-07-08 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-07-08 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
Market Intelligence
2025-12-17 Class III Recall: Winder Laboratories, LLC
2025-03-12 Class II Recall: SUN PHARMACEUTICAL INDUSTRIES INC
2024-03-27 Class II Recall: Hikma Pharmaceuticals USA Inc.
2023-11-08 Class III Recall: Edenbridge Pharmaceuticals, LLC
Generic Manufacturers
ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCALKEM LABORATORIES LTDDAVA PHARMACEUTICALS INCFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCINTERNATIONAL MEDICATION SYSTEMS LTDPADAGIS US LLCPHARMACEUTICAL ASSOCIATES INCPIRAMAL CRITICAL CARE INCPURDUE PHARMA LPRHODES PHARMACEUTICALS LPSPECGX LLCSUN PHARMACEUTICAL INDUSTRIES LTDTRIS PHARMA INCUPSHER SMITH LABORATORIES LLCWINDER LABORATOIRIES LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.